跳至主要内容
临床试验/DRKS00007163
DRKS00007163已完成未知

Safety and effectiveness of microwave ablation (MWA)as a new thermal ablation technique for lungmalignancies (SAMANTHA) - SAMANTHA

Otto-von-Guericke-Universität MagdeburgMedizinische Fakultät0 个研究点目标入组 36 人开始时间: 2016年5月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Primary lung cancer (NSCLC)
  • o Functional irresectable
  • FEV1 < 30% and/or
  • diffusion capacity <30% and/or
  • mx. O2-uptake in spiro-ergometry < 15% and/or
  • EF<30% in echocardiography
  • oRefusal of surgical treatment by patient
  • oInterdisciplinary decision for microablative treatment
  • 2. Secondary lung malignancies
  • oInterdisciplinary decision for microablative treatment
  • - Age > 18 years
  • - Tumor size between 5mm and 50mm
  • - Positive proof of vitality:
  • oFDG-uptake in FDG-PET-CT (positive biopsy needed in case of doubts in a positive PET finding in interdisciplinary consensus)
  • osize increase of target lesion in CT
  • opositive biopsy of the target lesion
  • - Distance between target lesion and heart > 20mm

排除标准

  • - Life expectancy <13 month
  • - Contraindications for a CT-guided intervention
  • - Contraindications for a microwave ablation
  • - Abnormal bleeding parameters (PTT < 50%; platelet count < 50x109/L)
  • - Respiratory insufficiency (pO2 < 60 or pCO2 > 45)
  • - Myocardial infarction or stroke within 2 month before intervention

研究者

发起方
Otto-von-Guericke-Universität MagdeburgMedizinische Fakultät

相似试验